MD MEDICAL GROUP ANNOUNCES START OF TRADING ON THE MOSCOW EXCHANGE
9 November 2020, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces start of trading of the Company’s Global Depositary Receipts (GDRs) (ISIN US55279C2008) on the MOEX, included into the Level 1 quotation list. The trading ticker is MDMG. Quotation is done in Russian rubles.
CEO of MD Medical Group Mark Kurtser and Chairman of the Moscow Exchange’s Executive Board Yury Denisov took part in the ceremony, launching the start of trading and broadcast on the MOEX website.
Mark Kurtser, CEO of MD Medical Group, said:
“We consider the listing on the Moscow Exchange as an important step in broadening the pool of our shareholders, bringing in new Russian institutional and retail investors who know well the “Mother and Child” brand. I expect that this will contribute to promoting liquidity of our GDRs on both trading platforms. The start of trading on MOEX coincides with the release of our operational results for the 9 months of 2020. They demonstrate stability and growth of the Company, inspite of challenging circumstances due to the pandemic.”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 (495) 139-87-40, ext. 16329
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements. No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2021 2020 2019 2018 2017 2016 2015 2014 2013 2012